A detailed history of Kessler Investment Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kessler Investment Group, LLC holds 5,687 shares of LLY stock, worth $4.55 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
5,687
Previous 2,476 129.68%
Holding current value
$4.55 Million
Previous $2.24 Million 124.81%
% of portfolio
2.73%
Previous 1.25%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$772.14 - $960.02 $2.48 Million - $3.08 Million
3,211 Added 129.68%
5,687 $5.04 Million
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $1.09 Million - $1.46 Million
1,840 Added 289.31%
2,476 $1.93 Million
Q3 2023

Oct 18, 2023

SELL
$434.7 - $599.3 $14,345 - $19,776
-33 Reduced 4.93%
636 $341,000
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $11,574 - $15,476
33 Added 5.19%
669 $313,000
Q1 2022

Apr 20, 2022

BUY
$234.69 - $291.66 $149,262 - $185,495
636 New
636 $182,000
Q4 2021

Feb 16, 2022

SELL
$224.85 - $279.04 $89,940 - $111,616
-400 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $3.46 Million - $4.17 Million
-25,394 Reduced 98.45%
400 $66,000
Q1 2020

Apr 22, 2020

SELL
$119.05 - $147.35 $442,032 - $547,110
-3,713 Reduced 12.58%
25,794 $3.58 Million
Q4 2019

Jan 09, 2020

SELL
$106.92 - $132.43 $104,033 - $128,854
-973 Reduced 3.19%
29,507 $3.88 Million
Q3 2019

Oct 21, 2019

SELL
$106.79 - $116.16 $40,259 - $43,792
-377 Reduced 1.22%
30,480 $3.41 Million
Q2 2019

Jul 23, 2019

SELL
$110.79 - $129.32 $209,836 - $244,932
-1,894 Reduced 5.78%
30,857 $3.42 Million
Q1 2019

Apr 16, 2019

SELL
$111.31 - $131.02 $125,223 - $147,397
-1,125 Reduced 3.32%
32,751 $4.25 Million
Q4 2018

Jan 11, 2019

BUY
$105.9 - $118.64 $2.52 Million - $2.82 Million
23,804 Added 236.34%
33,876 $3.92 Million
Q3 2018

Oct 15, 2018

SELL
$85.86 - $107.31 $95,819 - $119,757
-1,116 Reduced 9.97%
10,072 $1.08 Million
Q2 2018

Jul 25, 2018

SELL
$75.7 - $86.88 $32,551 - $37,358
-430 Reduced 3.7%
11,188 $955,000
Q1 2018

Apr 13, 2018

SELL
$74.21 - $87.6 $94,098 - $111,076
-1,268 Reduced 9.84%
11,618 $899,000
Q4 2017

Jan 11, 2018

BUY
$81.94 - $87.89 $8,357 - $8,964
102 Added 0.8%
12,886 $1.09 Million
Q3 2017

Oct 16, 2017

BUY
$77.07 - $85.54 $985,262 - $1.09 Million
12,784
12,784 $1.09 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kessler Investment Group, LLC Portfolio

Follow Kessler Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kessler Investment Group, LLC with notifications on news.